[1] POLITI MT,OCHOA F,NETTI V,et al.Changes in cardiac Aquaporin expression during aortic valve replacement surgery with cardiopulmonary bypass[J].Eur J Card Surg,2020,57(3):556-564. [2] SURABHI S,KUMAR M.Comparison of ringer's lactate and plasmalyt-a as cardiopulmonary bypass prime for bypass associated acidosis in valve replacement surgeries[J].Ann Card Anaesth,2021,24(1):36-41. [3] 王剑冰,杨威,赵明博,等.Tempol预处理在大鼠窒息后心跳骤停 全脑缺氧缺血脑损伤模型中的保护作用及机制研究[J].临床和实验医学杂志,2019,18(20):2154-2157. [4] ALSTON R P,CONNELLY M,MACKENZIE C,et al.The depth of anaesthesia associated with the administration of isoflurane 2.5% during cardiopulmonary bypass[J].Perfusion, 2019,34(5):392-398. [5] 朱雅萍,宋一民,宋磊军,等.右美托咪定对体外循环下心脏瓣膜置换术患者的脑保护作用[J].药物评价研究,2017,40(3):356-360. [6] 吴雅娟,任建光,蔡迪盛,等.右美托咪定对体外循环心脏瓣膜置换术患者心肌损伤及术后认知功能的影响[J].中国药房,2018,29(10):1372-1376. [7] CARABIAS C S,CASTAO-LEN A M,NAVARRO B B,et al.Serum amyloid a1 as a potential intracranial and extracranial clinical severity biomarker in traumatic brain injury[J].J Intensive Care Med,2020,35(11):1180-1195. [8] 王冬婷,杨彪.血清S100β 蛋白 、NSE、CRP及IL-6水平与老年术后认知功能障碍的关系分析[J].海南医学院学报,2019,25(13):1016-1020. [9] 雷阳,王敏,陈莉,等.异丙酚和依托咪酯复合麻醉对体外循环心脏瓣膜置换术患者的效果研究[J].实用医院临床杂志,2021,18(6):207-210. [10] CAMMERTONI F,BRUNO P,PAVONE N,et al.Influence of cardiopulmonary bypass set-up and management on clinical outcomes after minimally invasive aortic valve surgery[J].Perfusion,2021,36(7):679-687. [11] 吴卞梁,黄义洲,刘月,等.体外循环下心脏瓣膜置换术后应用右美托咪定联合氯胺酮或瑞芬太尼的脑保护作用[J].中华老年多器官疾病杂志,2018,17(9):641-646. [12] 王欣,章放香.异氟醚预处理对体外循环心脏瓣膜置换术患者脑损伤的影响[J].中华麻醉学杂志,2018,38(1):88-91.
2023, Vol. 40 
